Solasia Pharma K.K.
TSE:4597.T
Overview | Financials
Company Name | Solasia Pharma K.K. |
Symbol | 4597.T |
Currency | JPY |
Price | 46 |
Market Cap | 10,016,954,940 |
Dividend Yield | 0% |
52-week-range | 23 - 71 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yoshihiro Arai |
Website | https://www.solasia.co.jp |
An error occurred while fetching data.
About Solasia Pharma K.K.
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD